CanadaBis Capital Inc. (CANB.V)

CAD 0.04

(0.0%)

Long Term Debt Summary of CanadaBis Capital Inc.

  • CanadaBis Capital Inc.'s latest annual long term debt in 2023 was 5.91 Million CAD , up 556.78% from previous year.
  • CanadaBis Capital Inc.'s latest quarterly long term debt in 2024 Q2 was 4.18 Million CAD , down -6.46% from previous quarter.
  • CanadaBis Capital Inc. reported annual long term debt of 900.81 Thousand CAD in 2022, down -28.63% from previous year.
  • CanadaBis Capital Inc. reported annual long term debt of 1.26 Million CAD in 2021, down -6.73% from previous year.
  • CanadaBis Capital Inc. reported quarterly long term debt of 3.96 Million CAD for 2024 Q3, down -5.82% from previous quarter.
  • CanadaBis Capital Inc. reported quarterly long term debt of 4.18 Million CAD for 2024 Q2, down -6.46% from previous quarter.

Annual Long Term Debt Chart of CanadaBis Capital Inc. (2023 - 2016)

Historical Annual Long Term Debt of CanadaBis Capital Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 5.91 Million CAD 556.78%
2022 900.81 Thousand CAD -28.63%
2021 1.26 Million CAD -6.73%
2020 1.35 Million CAD 18.45%
2019 1.14 Million CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%

Peer Long Term Debt Comparison of CanadaBis Capital Inc.

Name Long Term Debt Long Term Debt Difference
Aequus Pharmaceuticals Inc. 583.58 Thousand CAD -913.794%
Decibel Cannabis Company Inc. 32.34 Million CAD 81.71%
Delivra Health Brands Inc. 1.78 Million CAD -231.449%
Entourage Health Corp. 5.79 Million CAD -2.128%
Lifeist Wellness Inc. 868.65 Thousand CAD -581.092%
Cannara Biotech Inc. 39.73 Million CAD 85.112%
Medicure Inc. 229 Thousand CAD -2483.562%
PharmaCielo Ltd. 2.55 Million CAD -131.704%
Rubicon Organics Inc. - CAD -Infinity%
BioSyent Inc. 1.03 Million CAD -470.124%
Voyageur Pharmaceuticals Ltd. 40 Thousand CAD -14690.893%